Eduard Koman1, Ashwani Gupta2, Faiz Subzposh2, Heath Saltzman2, Steven P Kutalek2. 1. Department of Internal Medicine, Drexel University College of Medicine, New College Building 245 N. 15th Street, 6th Floor, Philadelphia, PA, 19102, USA. eduard.koman@drexelmed.edu. 2. Division of Cardiac Electrophysiology, Drexel University College of Medicine, Philadelphia, PA, USA.
Abstract
BACKGROUND: Subcutaneous implantable cardioverter-defibrillator (S-ICD) provides potential benefits in patients on hemodialysis (HD) by reducing the risk of blood stream infection and preserving vascular access sites. We evaluated the safety and efficacy of S-ICD in patients with end-stage renal disease (ESRD) on HD. METHODS: All consecutive patients implanted with S-ICD between October 2012 and April 2015 at our high-volume center were included in this retrospective, single-center study. Baseline demographics, procedural details, and short- as well as long-term outcomes were compared between patients on HD and not on HD. RESULTS: A total of 86 S-ICDs were implanted at our institution during the study period. Eighteen (21%) patients were on HD at the time of implant. HD patients were more likely to be implanted for secondary prevention. There was no statistically significant difference in procedural complications between the two groups. HD patients had a longer duration hospital stay after implant (3.6 ± 5.14 vs. 1.69 ± 2.29 days, p = 0.021). During a mean follow-up of 205 ± 208 days in the HD cohort and 242 ± 238 days in the non-HD cohort (p = 0.268), there was no device or blood stream infection in the HD group, compared with five device infections in the non-HD group. The incidence of inappropriate shocks was similar in both groups. All appropriate shocks were successful in terminating ventricular tachyarrhythmias in both groups. Patients on hemodialysis had worse inpatient as well as long-term mortality after S-ICD implant, compared with non-HD patients. CONCLUSIONS: Our study demonstrates the safety and efficacy of S-ICD in patients on HD. Despite representing a sicker patient population, HD patients implanted with S-ICD had similar procedural outcomes and inappropriate shocks. There was no device or blood stream-related infection in HD patients. All appropriate shocks for ventricular arrhythmias in HD patients were successful.
BACKGROUND: Subcutaneous implantable cardioverter-defibrillator (S-ICD) provides potential benefits in patients on hemodialysis (HD) by reducing the risk of blood stream infection and preserving vascular access sites. We evaluated the safety and efficacy of S-ICD in patients with end-stage renal disease (ESRD) on HD. METHODS: All consecutive patients implanted with S-ICD between October 2012 and April 2015 at our high-volume center were included in this retrospective, single-center study. Baseline demographics, procedural details, and short- as well as long-term outcomes were compared between patients on HD and not on HD. RESULTS: A total of 86 S-ICDs were implanted at our institution during the study period. Eighteen (21%) patients were on HD at the time of implant. HDpatients were more likely to be implanted for secondary prevention. There was no statistically significant difference in procedural complications between the two groups. HDpatients had a longer duration hospital stay after implant (3.6 ± 5.14 vs. 1.69 ± 2.29 days, p = 0.021). During a mean follow-up of 205 ± 208 days in the HD cohort and 242 ± 238 days in the non-HD cohort (p = 0.268), there was no device or blood stream infection in the HD group, compared with five device infections in the non-HD group. The incidence of inappropriate shocks was similar in both groups. All appropriate shocks were successful in terminating ventricular tachyarrhythmias in both groups. Patients on hemodialysis had worse inpatient as well as long-term mortality after S-ICD implant, compared with non-HDpatients. CONCLUSIONS: Our study demonstrates the safety and efficacy of S-ICD in patients on HD. Despite representing a sicker patient population, HDpatients implanted with S-ICD had similar procedural outcomes and inappropriate shocks. There was no device or blood stream-related infection in HDpatients. All appropriate shocks for ventricular arrhythmias in HDpatients were successful.
Authors: Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke Journal: Circulation Date: 2013-08-27 Impact factor: 29.690
Authors: Martin C Burke; Michael R Gold; Bradley P Knight; Craig S Barr; Dominic A M J Theuns; Lucas V A Boersma; Reinoud E Knops; Raul Weiss; Angel R Leon; John M Herre; Michael Husby; Kenneth M Stein; Pier D Lambiase Journal: J Am Coll Cardiol Date: 2015-04-28 Impact factor: 24.094
Authors: Christine Tompkins; Rhondalyn McLean; Alan Cheng; Jeffrey A Brinker; Joseph E Marine; Saman Nazarian; David D Spragg; Sunil Sinha; Henry Halperin; Gordon F Tomaselli; Ronald D Berger; Hugh Calkins; Charles A Henrikson Journal: J Cardiovasc Electrophysiol Date: 2011-04-13
Authors: Michael P Brunner; Edmond M Cronin; Valeria E Duarte; Changhong Yu; Khaldoun G Tarakji; David O Martin; Thomas Callahan; Daniel J Cantillon; Mark J Niebauer; Walid I Saliba; Mohamed Kanj; Oussama Wazni; Bryan Baranowski; Bruce L Wilkoff Journal: Heart Rhythm Date: 2014-01-17 Impact factor: 6.343
Authors: Patrick H Pun; Anne S Hellkamp; Gillian D Sanders; John P Middleton; Stephen C Hammill; Hussein R Al-Khalidi; Lesley H Curtis; Gregg C Fonarow; Sana M Al-Khatib Journal: Nephrol Dial Transplant Date: 2014-11-17 Impact factor: 5.992
Authors: Mikhael F El-Chami; Mathew Levy; Heval M Kelli; Mary Casey; Michael H Hoskins; Abhinav Goyal; Jonathan J Langberg; Anshul Patel; David Delurgio; Michael S Lloyd; Angel R Leon; Faisal M Merchant Journal: J Cardiovasc Electrophysiol Date: 2015-06-16
Authors: Rajiv K Dhamija; Henry Tan; Edward Philbin; Roy O Mathew; Mandeep S Sidhu; Jeffrey Wang; Basil Saour; Syed S Haqqie; Gerald Beathard; Alexander S Yevzlin; Loay Salman; William E Boden; Gary Siskin; Arif Asif Journal: Am J Kidney Dis Date: 2015-04-22 Impact factor: 8.860
Authors: Paul L Hess; Anne S Hellkamp; Eric D Peterson; Gillian D Sanders; Hussein R Al-Khalidi; Lesley H Curtis; Bradley G Hammill; Patrick H Pun; Jeptha P Curtis; Kevin J Anstrom; Stephen C Hammill; Sana M Al-Khatib Journal: Circ Arrhythm Electrophysiol Date: 2014-07-18
Authors: Heather Bloom; Brian Heeke; Angel Leon; Fernando Mera; David Delurgio; John Beshai; Jonathan Langberg Journal: Pacing Clin Electrophysiol Date: 2006-02 Impact factor: 1.976
Authors: Milena Leo; Alexander J Sharp; Andre Briosa E Gala; Michael T B Pope; Timothy R Betts Journal: J Interv Card Electrophysiol Date: 2022-07-14 Impact factor: 1.759
Authors: Patrick H Pun; Craig S Parzynski; Daniel J Friedman; Gillian Sanders; Jeptha P Curtis; Sana M Al-Khatib Journal: Clin J Am Soc Nephrol Date: 2020-09-23 Impact factor: 8.237
Authors: Rohit J Timal; Ioannis Karalis; Jose M Montero Cabezas; Joris I Rotmans; Liselotte C R Hensen; Maurits S Buiten; Mihaly K de Bie; Lieselot van Erven; Hein Putter; Martin J Schalij; Ton J Rabelink; J Wouter Jukema Journal: Cardiol Cardiovasc Med Date: 2022-04-14